Company Filing History:
Years Active: 2022
Title: The Innovations of Shin Ae Yi
Introduction
Shin Ae Yi is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work is crucial in the ongoing fight against cancer.
Latest Patents
Shin Ae Yi holds a patent for an "Anti-PD-L1 antibody and use thereof." This patent discloses an anti-PD-L1 antibody or an antigen-binding fragment, along with a nucleic acid encoding the same. It also includes a vector containing the nucleic acid, a cell transformed with the vector, and methods for producing the antibody or its fragments. Furthermore, the patent outlines a pharmaceutical composition for preventing or treating cancer and a composition for co-administration with other antibodies.
Career Highlights
Shin Ae Yi is currently associated with Pharmabcine Inc., where he continues to innovate in the field of cancer treatment. His work has the potential to impact many lives by providing new therapeutic options for patients.
Collaborations
He collaborates with talented coworkers, including Sungho Ahn and Miju Park, who contribute to the research and development efforts at Pharmabcine Inc.
Conclusion
Shin Ae Yi's contributions to biotechnology, particularly through his patent on anti-PD-L1 antibodies, highlight his role as an influential inventor in the fight against cancer. His ongoing work promises to lead to significant advancements in cancer therapies.